Clobazam
- Product NDC
- 67877-664
- 11-digit product format
- 678770664
- Labeler code
- 67877
- Product ID
- 67877-664_f9dc8ac4-86be-49ab-9c2c-c60658f49d8f
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Clobazam
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Ascend Laboratories, LLC
- Application
- ANDA212714
- Marketing category
- ANDA
- Marketing start
- 2023-10-18
- Substance
- CLOBAZAM
- Active strength
- 5 mg/1
- Pharmacologic classes
- Benzodiazepine [EPC], Benzodiazepines [CS], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA]
- DEA schedule
- CIV
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Clobazam
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| CLOBAZAM | 5 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 2MRO291B4U |
| Rxcui | 199450, 246172, 427538 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 67877-664 | CLOBAZAM TABLET [ASCEND LABORATORIES, LLC] | 17 | Current NDC, 5 package rows | 20241130_a77ffbdd-4e3e-4ec4-b0fa-b51ee610df0f.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 67877-664-01 | 67877066401 | 1 BOTTLE in 1 CARTON (67877-664-01) / 100 TABLET in 1 BOTTLE | 1 bottle | 2023-10-18 | No | No | Current |
| 67877-664-05 | 67877066405 | 500 TABLET in 1 BOTTLE (67877-664-05) | 500 tablet | 2023-10-18 | No | No | Current |
| 67877-664-33 | 67877066433 | 1 BLISTER PACK in 1 CARTON (67877-664-33) / 10 TABLET in 1 BLISTER PACK | 1 blister pack | 2023-10-18 | No | No | Current |